Last reviewed · How we verify
NCT05711108
Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities
trial in Diabetes in 86 participants. Completed in 31 December 2024.
30 November 2024
Quick facts
| Lead sponsor | Joslin Diabetes Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 86 |
| Start date | 19 January 2022 |
| Primary completion | 30 November 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across United States |
Conditions studied
- Diabetes — all drugs for Diabetes →
- Hypoglycemia — all drugs for Hypoglycemia →
- Aging — all drugs for Aging →
Sponsor
Joslin Diabetes Center — full company profile →
Who can join
65 and older, any sex, with Diabetes or Hypoglycemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To prospectively determine the burden of hypoglycemia (minutes spent below 70 mg/dl per day, measured by continuous glucose monitor (CGM)) among residents of long term care facilities (LTC) with a diagnosis of type 1 or type 2 diabetes including key clinical subgroups (living in skilled nursing facility (SNF) or nursing home (NH), on different hypoglycemic medications). This aim will be achieved by recruiting 300 residents with diabetes in 4 LTC facilities. All participants will undergo masked CGM for 10 days.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05711108
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes
Currently open trials in the same condition.
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07479134 — Production of Stem Cells for the Generation of Pancreatic Cells · NA · recruiting
- NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
- NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
- NCT07417865 — ECHO Diabetes FQHC · recruiting
Other Joslin Diabetes Center trials
Trials by the same sponsor.
- NCT07271043 — Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incre · NA · recruiting
- NCT07467694 — Postnatal Exercise to Activate Baby's Brown Fat · NA · recruiting
- NCT06511310 — Exercise, Brain Activity, and Weight Maintenance · NA · recruiting
- NCT07082478 — External Carotid Blood Flow in Individuals With Post-Bariatric Hypoglycemia · recruiting
- NCT07468188 — Diabetes Body Project 2 · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05711108 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Joslin Diabetes Center
- Last refreshed: 22 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05711108.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing